Bharat Immunological & Biologicals Corporation Ltd. - Research Center
524663 BIBCL Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 44.61 | 78.39 | 85.33 | 66.84 | 83.65 |
| Operating profit | -18.47 | -4.99 | -20.87 | -10.41 | -8.92 |
| Interest | 7.04 | 5.59 | 4.78 | 4.74 | 1.49 |
| Gross profit | -22.71 | -9.47 | -23.97 | -13.97 | -7.78 |
| EPS (Rs) | -3.95 | -2.03 | -4.19 | -2.36 | -1.29 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 2.80 | 1.10 | 1.68 | 1.18 | 2.64 |
| Stock adjustment | 5.95 | 0.44 | 20.15 | -12.99 | -13.35 |
| Raw material | 33.04 | 59.19 | 61.06 | 68.95 | 86.63 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 15.32 | 13.85 | 14.44 | 11.37 | 9.38 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 8.77 | 9.89 | 10.56 | 9.91 | 9.91 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.15 | 0.21 | 0.24 | 0.24 | 0.28 |
| Taxation | -5.79 | -0.93 | -6.10 | -3.99 | -2.50 |
| Net profit / loss | -17.06 | -8.75 | -18.11 | -10.21 | -5.56 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -41.40 | -6.36 | -24.46 | -15.57 | -10.67 |
| GPM (%) | -47.89 | -11.92 | -27.55 | -20.53 | -9.01 |
| NPM (%) | -35.98 | -11.01 | -20.82 | -15.01 | -6.44 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis